Hello and welcome to the details of WHO recommends malaria vaccine, roll out in early 2024 in some African countries, dengue for six- to 16-year-olds and now with the details
Nevin Al Sukari - Sana'a - The World Health Organisation recommended today the use of a second malaria vaccine to curb the life-threatening disease spread to humans by some mosquitoes. — Reuters pic
GENEVA, Oct 2 — The World Health Organisation (WHO) recommended today the use of a second malaria vaccine to curb the life-threatening disease spread to humans by some mosquitoes.
“Almost exactly two years ago, W.H.O. recommended the broad use of the world’s first malaria vaccine called RTS,S,” WHO chief Tedros Adhanom Ghebreyesus told a briefing in Geneva.
“Today, it gives me great pleasure to announce that WHO is recommending a second vaccine called R21/Matrix-M to prevent malaria in children at risk of the disease.”
R21/Matrix-M, developed by Britain’s University of Oxford, will be rolled out in some African countries in early 2024 and available mid-2024 in other countries, Tedros said, adding that doses would cost between US$2 and US$4 (RM9.43 and RM18.87).
“WHO is now reviewing the vaccine for prequalification, which is WHO stamp of approval, and will enable GAVI (a global vaccine alliance) and Unicef to buy the vaccine from manufacturers,” Tedros said.
The R21/Matrix-M is mass manufactured by Serum Institute of India and uses Novavax’s Matrix M adjuvant.
Tedros added the agency had also recommended Takeda Pharmaceuticals’ vaccine against dengue called Qdenga for children aged six to 16 years living in areas where the infection is a significant public health problem.
Dengue, common in tropical and subtropical climates, is a viral infection spread from mosquitoes to people.
Takeda’s vaccine was shown in trials to be effective against all 4 stereotypes of the virus in people who were previously infected by dengue, Hanna Nohynek, chair of WHO’s Strategic Advisory Group of Experts on Immunisation, told journalists.
She added, however, that there remained uncertainty about its performance against stereotype 3 and 4 in people who have not been infected previously.
The WHO’s strategic advisory group also recommended a simplified single dose regime for primary immunisation for most Covid-19 vaccines to improve acceptance of the shots at a time when most people have had at least one prior infection
The agency added that any monovalent or bivalent vaccine could be used given that monovalent vaccines that target the XBB.1.5 variant — the dominant variant in many places this year — are not available in many countries. — Reuters
These were the details of the news WHO recommends malaria vaccine, roll out in early 2024 in some African countries, dengue for six- to 16-year-olds for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.
